Mitchell Evers Selected Research

Mitchell Evers Research Topics

9	Neoplasms (Cancer) 03/2024 - 01/2019
2	Neuralgia (Stump Neuralgia) 01/2023 - 10/2021
2	Neuroblastoma 01/2023 - 10/2021
1	Communicable Diseases (Infectious Diseases) 09/2023
1	Lymphoma (Lymphomas) 10/2021
1	Pain (Aches) 10/2021
1	Hypersensitivity (Allergy) 12/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018

7	Immunoglobulin G (IgG)IBA 03/2024 - 01/2019
7	AntibodiesIBA 01/2023 - 01/2019
6	Immunoglobulin A (IgA)IBA 09/2023 - 01/2019
4	Monoclonal AntibodiesIBA 10/2021 - 01/2018
3	Complement System Proteins (Complement)IBA 03/2024 - 01/2019
2	Fc(alpha) receptorIBA 09/2023 - 01/2023
2	dinutuximabIBA 01/2023 - 10/2021
1	IgA receptor (protein B)IBA 10/2021
1	CaspasesIBA 10/2021
1	Rituximab (Mabthera)FDA Link 12/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Cetuximab (Erbitux)FDA Link 01/2019
1	necitumumabIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Panitumumab (Vectibix)FDA Link 01/2019

4	Therapeutics 01/2023 - 01/2019
2	Immunotherapy 09/2023 - 01/2023